| Chairman |
|
Liu Xiaolin |
| Business Nature |
| 醫療保健 (Health Care) |
| Board Members |
Chairman: Liu Xiaolin
Executive Director: Huang Song, Yin Ye
Independent Non-executive Director: Yan Guoxiang, Guo Yuantao, Zhang Xiao.
|
| Principle Business |
|
The principal activities of the Group are engaged in the provision of medical laboratory testing services and health check services; brokerage services; tumor immune call therapy, immune cell storage and health management services; the manufacture, research, development, sale and distribution of health related and pharmaceutical products; trading of securities; money lending; and the provision of logistic services in Mainland China and Hong Kong. |
| Related Indexes | |
| Major Shareholders |
| Liu Xiaolin | 534,192,546 | 54.75% | 2026/03/30 | | Ko Chun Shun Johnson | 95,545,000 | 9.79% | 2025/06/30 |
|
| Related Stocks | |
|
|
|